Overview

A Study to Assess the Effect of Itraconazole, Phenytoin, and Gemfibrozil on the Drug Levels of BMS-986166 in Healthy Participants

Status:
Recruiting

Trial end date:
2022-01-19

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the effect of itraconazole, phenytoin and gemfibrozil on the drug levels of BMS-986166 and its active metabolite BMT- 121795. Participants will be randomly assigned to one of four groups and will remain in the study clinic for the duration of treatment.

Phase:

Phase 1

Details

Lead Sponsor:

Bristol-Myers Squibb

Treatments:

Gemfibrozil
Itraconazole
Phenytoin